[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100476095":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":44,"collaborators":20,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":20,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":20,"enrollmentInfo":57,"targetDuration":20,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":20,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Stanford University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Platelet rich plasma treatment arm","EXPERIMENTAL","After consent in obtained, the patient will undergo a blood draw (12 tsp) to prepare the PRP infusion. The use of a centrifuge and an Arteriocyte Magellan kit are necessary for the PRP preparation. After injection of local anesthesia, PRP will be injected into each testicle.",[13],"Biological: Platelet rich plasma",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","Platelet rich plasma","Patients will undergo a blood draw (12 tsp) to prepare the PRP infusion. The use of a centrifuge and an Arteriocyte Magellan kit are necessary for the PRP preparation. After injection of local anesthesia, PRP will be injected into each testicle.\n\n* On the third month after the testicular PRP procedure, a TESE will be performed\n* If the procedure is successful a new IVF cycle using the sperm procured from the procedure will be done.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Satvir Basran","CONTACT","650-723-0948","sbasran@stanford.edu",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Stanford Urology Clinic","RECRUITING","Stanford","California","94304","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-122.16608,37.42411,{"lat":40,"lon":39},[43],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Michael Eisenberg","Principal Investigator","100476095","platelet-rich-plasma-testis-treatment-for-infertile-men-100476095",false,"NCT05479474","Platelet Rich Plasma Testis Treatment for Infertile Men","Platelet Rich Plasma Testis","Inclusion Criteria:\n\n* Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy\n\nExclusion Criteria:\n\n\\-","MALE","18 Years",{"count":58,"type":59},10,"ESTIMATED","INTERVENTIONAL",[62],"NA","Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.",[65,66,67],"Male Infertility","Nonobstructive Azoospermia","Azoospermia","2026-01-12",{"date":70,"type":71},"2026-01-13","ACTUAL",{"date":73,"type":71},"2023-01-18",{"date":75,"type":59},"2026-12-31",{"name":5,"class":6},1]